Europe Multiplex Assays Market– Industry Trends and Forecast to 2026

  • In Vitro Diagnostics
  • Published Report
  • Nov 2018
  • Europe
  • 350 Pages
  • No of Tables: 24
  • No of Figures: 131

Europe Multiplex Assays Market, By Products & Services (Reagents & Consumables, Instruments & Accessories, Software & Services), Type (Nucleic Acid Multiplex Assays, Protein Multiplex Assays, Cell-Based Multiplex Assays), Technology (Protein Microarray, Polymerase Chain Reaction, Multiplex Real-Time PCR, Flow Cytometry, Fluorescence Detection, Luminescence, Others), Application (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Geography (Europe)– Industry Trends and Forecast to 2026

A Multiplex Assay is a type of immunoassay that uses magnetic beads or non-magnetic beads to determine multiple analyte in a single sample. A multiplex assay is as similar as that of an ELISA but here in multiplex assays, beads are present that are useful in binding the capture antibody. Multiplex assays are common because of their benefits nowadays in research than in clinical settings.

Protein immunoassays give data regarding quantities and forms of endogenous proteins in a given sample. Uniplex enzyme immunoassays such as enzyme-linked immunosorbent assay (ELISA) used for protein measurement from past years but they are time consuming and found to be more costly. When comparing ELISA with multiplex assays, multiplex assays offer more accurate quantitative information in a single analysis for number of analysis.

Europe multiplex assays market is expected to reach a healthy CAGR of 7.1% in the forecast period of 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation: Europe Multiplex Assays Market 

A Europe multiplex assay market is categorized into five notable segments which are products & services, type, technology, application and end user.

  • On the basis of product & services the market is segmented into reagents & consumables, instruments & accessories and software and services. In 2019, reagents & consumables segment is expected to dominate the Europe multiplex assays market with 64.5% market share and is expected to grow at the highest CAGR of 7.5% in the forecast period of 2019 to 2026.

    • In September 2014, F. Hoffmann-La Roche Ltd launched new fully automated molecular diagnostic systems named as cobas 6800/8800 Systems. These systems offer results in a very short time along with highest testing capacity. With this launch the company has increased their product portfolio in market in diagnostics field.

  • On the basis of type, the market is segmented into protein multiplex assays, nucleic acid multiplex assays and cell-based multiplex assays. Protein multiplex assays are sub-segmented into planar protein assays and bead-based protein assays. Nucleic acid multiplex assays are sub-segmented into planar nucleic acid assays and bead-based nucleic acid assays.

    • In 2019, a nucleic acid multiplex assay segment is expected to dominate the Europe multiplex assays market with 49.1% market share and is expected to grow at the highest CAGR of 7.6%in the forecast period of 2019 to 2026.
    • In June 2015, Abcam plc, launched a range of multiplex miRNA profiling assays. The launched assay has the ability to give high-throughput validation of miRNA biomarkers on the basis of Abcam’s new Firefly particle technology. Launching this product was the opportunities to Abcam for its Firefly particle technology that bring the Europe researchers for miRNA research.

  • On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, polymerase chain reaction (PCR), protein microarray and others. In 2019, protein microarray segment is expected to dominate the Europe multiplex assays market with 35.2% market share and is expected to grow at the CAGR of 7.3% in the forecast period of 2019 to 2026. However, polymerase chain reaction (PCR) segment is expected to grow at the highest CAGR of 7.8% in the forecast period of 2019 to 2026.

    • In July 2018, BD (Becton, Dickinson and Company) launched BD AbSeq assay for simultaneous RNA and protein expression analysis assay. The systems include the BD Rhapsody Express system and the BD single-cell multiplexing kit. Launch of this product helped in increasing one more product in company’s product portfolio.

  • On the basis of application the market is segmented into research & development and clinical diagnostics. Research & development is sub-segmented into drug discovery & development and biomarker discovery & validation. Clinical diagnostics is sub-segmented into infectious diseases, cancer, cardiovascular diseases, infectious diseases, autoimmune diseases, allergies, nervous system disorders, metabolism & endocrinology disorders and others. In 2019, clinical diagnostics segment is expected to dominate the Europe multiplex assays market with 55.8% market share and is expected to grow at the highest CAGR of 7.6% in the forecast period of 2019 to 2026.

    • In June 2015, MESO SCALE DIAGNOSTICS, LLC. at the 2015 AAPS National Biotechnology Conference, launched its new Biomarker Services. This service offered biomarker screening and assay development services to their customer for discovery and exploratory studies to validated products.

  • On the basis of end user the market is segmented into pharmaceutical & biotechnology companies, research institutes, hospitals, clinical laboratories and others. In 2019, hospitals segment is expected to dominate the Europe multiplex assays market with 37.1% market share and is expected to grow at the highest CAGR of 8.0% in the forecast period of 2019 to 2026.

    • In January 2016, Thermo Fisher Scientific acquired Affymetrix (U.S.). The acquisition of Affymetrix with Thermo Fisher Scientific helped Thermo Fisher Scientific Company in strengthening the biosciences field and creating new market opportunities for in genetic analysis.

Competitive Analysis: Europe Multiplex Assays Market 

Some of the prominent participants operating in this market are BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Cepheid, Siemens AG, Hologic Inc., Luminex Corporation. , MESO SCALE DIAGNOSTICS, LLC., QIAGEN, PerkinElmer Inc. , Illumina, Inc. , AGENA BIOSCIENCE, INC. , Olink , Randox Laboratories Ltd., Bio-Techne. , Agilent Technologies, Agilent Technologies, Sysmex Corporation and among others..

Product launch:

  • In June 2018, QIAGEN (Germany) launched the QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit. This kit was launched along with a new generation of reagents that allows the most accurate quantification and qualitative analysis from complex microbiome samples. This product provides a comprehensive and robust profiling of bacterial and fungal communities. With this launch, one more product got added to the company’s product portfolio.
  • In May 2018, Bio-Rad Laboratories, Inc. launched the Bio-Plex Pro Human Cytokine Screening Panel. This product is the first validated high-performance multiplex assay on the market. The panel has the ability to identify and quantify 48 different analytes. This is applicable for identification and estimation of analytes for heart disease, autoimmunity and allergy, cancer, and many other conditions. Launching this product helped the company in increasing their product portfolio.
  • In June 2018, QIAGEN launched the QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit. This kit was launched with a new generation of reagents to allow the most accurate microbial community profiling from complex microbiome samples. This product provides comprehensive and robust profiling of bacterial and fungal communities. With this launch one more product got added to company’s product portfolio.
  • In August 2017, Quanterix Corporation announced expansion for its single molecule array, or Simoa, technology platform portfolio by launching the new Quanterix SR-Plex benchtop instrument. Digital health revolution and life science research increased multiplexing capabilities. This launch enabled a transformation to asymptomatic medicine and precision health and also increased the company’s product portfolio.

Research Methodology: Europe Multiplex Assays Market 

Primary Respondents: Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers


SKU-

LIST OF TABLES EUROPE MULTIPLEX ASSAYS MARKET

TABLE 1 COST OF FEW MULTIPLEX INSTRUMENTS TABLE 2 EUROPE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 3 EUROPE REAGENTS & CONSUMABLES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 4 EUROPE INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 5 EUROPE INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 6 EUROPE MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 7 EUROPE NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 8 EUROPE NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 9 EUROPE PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 10 EUROPE PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 11 EUROPE CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 12 EUROPE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 13 EUROPE PROTEIN MICROARRAY IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 14 EUROPE POLYMERASE CHAIN REACTION IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 15 EUROPE MULTIPLEX REAL-TIME PCR IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 16 EUROPE FLOW CYTOMETRY IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 17 EUROPE FLUORESCENCE DETECTION IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 18 EUROPE LUMINESCENCE IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 19 EUROPE OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 20 EUROPE MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 21 EUROPE CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 22 EUROPE CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 23 EUROPE RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 24 EUROPE RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 25 EUROPE MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 26 EUROPE HOSPITALS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 27 EUROPE CLINICAL LABORATORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 28 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 29 EUROPE RESEARCH INSTITUTES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 30 EUROPE OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 31 EUROPE MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 32 EUROPE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 33 EUROPE MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 34 EUROPE NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 35 EUROPE PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 36 EUROPE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 37 EUROPE MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 38 EUROPE CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 39 EUROPE RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 40 EUROPE MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 41 GERMANY MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 42 GERMANY MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 43 GERMANY NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 44 GERMANY PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 45 GERMANY MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 46 GERMANY MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 47 GERMANY CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 48 GERMANY RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 49 GERMANY MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 50 U.K. MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 51 U.K. MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 52 U.K. NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 53 U.K. PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 54 U.K. MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 55 U.K. MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 56 U.K. CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 57 U.K. RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 58 U.K. MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 59 FRANCE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 60 FRANCE MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 61 FRANCE NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 62 FRANCE PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 63 FRANCE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 64 FRANCE MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 65 FRANCE CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 66 FRANCE RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 67 FRANCE MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 68 ITALY MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 69 ITALY MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 70 ITALY NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 71 ITALY PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 72 ITALY MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 73 ITALY MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 74 ITALY CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 75 ITALY RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 76 ITALY MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 77 SPAIN MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 78 SPAIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 79 SPAIN NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 80 SPAIN PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 81 SPAIN MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 82 SPAIN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 83 SPAIN CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 84 SPAIN RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 85 SPAIN MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 86 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 87 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 88 SWITZERLAND NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 89 SWITZERLAND PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 90 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 91 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 92 SWITZERLAND CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 93 SWITZERLAND RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 94 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 95 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 96 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 97 NETHERLANDS NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 98 NETHERLANDS PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 99 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 100 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 101 NETHERLANDS CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 102 NETHERLANDS RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 103 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 104 BELGIUM MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 105 BELGIUM MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 106 BELGIUM NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 107 BELGIUM PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 108 BELGIUM MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 109 BELGIUM MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 110 BELGIUM CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 111 BELGIUM RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 112 BELGIUM MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 113 IRELAND MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 114 IRELAND MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 115 IRELAND NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 116 IRELAND PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 117 IRELAND MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 118 IRELAND MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 119 IRELAND CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 120 IRELAND RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 121 IRELAND MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 122 AUSTRIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 123 AUSTRIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 124 AUSTRIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 125 AUSTRIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 126 AUSTRIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) TABLE 127 AUSTRIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 128 AUSTRIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 129 AUSTRIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 130 AUSTRIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 131 REST OF EUROPE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19